These treatments offer effective solutions for patients with obesity and metabolic disorders, making them an attractive option for healthcare providers looking to enter the space
When you need to run an experiment, you pull out and thaw only one aliquot
Not for clinical, therapeutic, or diagnostic use
The long-term health benefits sustained weight loss, improved metabolic markers, reduced cardiovascular risk far outweigh a few weeks of adjustment
The reasons for the lack of benefit of DPP-4 inhibitors on major cardiovascular outcomes could theoretically be related to the relatively short duration of follow-up in the landmark trials
Its half-life is 15 to 20 hours, meaning it takes 15 hours to eliminate half of it from your body. A missed dose should be taken as soon as remembered